An observational study in Ion Beam Radiation Therapy for Tumor Patients, sponsored by EBG MedAustron GmbH. Recruiting at 1 site in Austria. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by EBG MedAustron GmbH · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.
During and up to 10 years after radiation therapy data regarding tumor control and treatment response as well as acute and late toxicities will be collected at regular time intervals. Additionally quality of life and sociodemographic status will be assessed in all study patients and neurocognitive assessment will be performed in patients undergoing ion radiation of the brain.
EBG MedAustron GmbH is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients treated with ion beam therapy at MedAustron
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All patients treated with ion beam therapy at MedAustron who consent to the participation in the registry.
Radiation: Protons and Carbon Ions
Therapy response
Therapy Response according to RECIST Version 1.1
Time frame: 10 years
Overall survival
Time frame: 10 years
Progression-free survival
Time frame: 10 years
Local progression-free survival
Time frame: 10 years
Cause-specific survival
Time frame: 10 years
Toxicity according to NCI CTCAE
Acute/late toxicity according to CTCAEv4.03, June 14,2010
Time frame: 10 years
EORTC-QLQ-C30
Patient-reported quality of life
Time frame: Through study completion, at 3, 5, and 10 years
EORTC-QLQ-BN20
Patient-reported quality of life for brain cancer patients
Time frame: Through study completion, at 3, 5, and 10 years
EORTC-QLQ-PR25
Patient-reported quality of life for prostate cancer patients
Time frame: Through study completion, at 3, 5, and 10 years
Neurocognitive test battery
Change in cognition from baseline to endpoint as measured by standardized subtests of test battery
Time frame: Through study completion, at 3, 5, and 10 years
Started Dec 2016 (actual). Primary completion is estimated for Dec 2031, 180 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
EBG MedAustron GmbH